Intracranial tumors can be resected safely in elderly
(HealthDay)—Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research ...
Cancer
Oct 21, 2012 |
not rated yet |
0
Researchers make breakthrough on immune system and brain tumors
In what could be a breakthrough in the treatment of deadly brain tumors, a team of researchers from Barrow Neurological Institute and Arizona State University has discovered that the immune system reacts differently to different ...
Cancer
Sep 27, 2012 |
5 / 5 (1) |
0
DNA deletions promote cancer, collateral damage makes it vulnerable
Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vul ...
Cancer
Aug 15, 2012 |
4.5 / 5 (2) |
0
|
Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Im ...
Immunology
Aug 15, 2012 |
5 / 5 (1) |
0
|
Study suggests new treatment target for glioblastoma multiforme
A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target ...
Cancer
Aug 01, 2012 |
5 / 5 (1) |
0
|
Key mutations discovered for medulloblastoma -- most common childhood brain cancer
Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and several collaborating institutions have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common ...
Cancer
Jul 22, 2012 |
5 / 5 (1) |
0
|
Identification of a novel target for glioblastoma treatment
(Medical Xpress) -- A recent study from scientists at the Friedrich Miescher Institute for Biomedical Research has identified a novel target for the treatment of malignant brain tumors. The scientists found ...
Cancer
Jun 18, 2012 |
5 / 5 (1) |
0
|
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
Cancer
May 16, 2012 |
not rated yet |
0
Research yields new clues to how brain cancer cells migrate and invade
Researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue. ...
Cancer
May 01, 2012 |
5 / 5 (1) |
0
|
A promising discovery for breast cancer therapy
(Medical Xpress) -- Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research ...
Cancer
Apr 20, 2012 |
not rated yet |
0
A culprit behind brain tumor resistance to therapy
Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.
Cancer
Mar 05, 2012 |
not rated yet |
0
Researchers helping map brain cancer genome
Fueled by the hope of finding better treatments, patients like Kenneth Jacques are helping medical science map the entire genetic sequence of a few types of brain tumors.
Cancer
Feb 23, 2012 |
not rated yet |
0
'First-in-human' drug for malignant glioma available in experimental trial
The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form ...
Cancer
Feb 15, 2012 |
5 / 5 (2) |
0
A thought-provoking new therapeutic target for brain cancer?
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Cancer
Feb 01, 2012 |
not rated yet |
0
New brain vaccine aims to turn fatal disease into chronic illness
When U.S. Sen. Edward Kennedy was diagnosed with a glioblastoma of the brain in May 2009, doctors understood there was little chance he could survive it. He died that August.
Cancer
Nov 29, 2011 |
not rated yet |
0
